Atlas Trials

Compare the Effect of Eupatilin and Rebamipide on the Prevention of Gastroenteropathy

Clinical trial NCT04885751 · UNKNOWN

Trial details

NCT number
NCT04885751
Sponsor
Seoul National University Boramae Hospital
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Rheumatoid ArthritisOsteoarthritisAnkylosing SpondylitisOther Musculoskeletal DisorderGastric UlcerEnteritisNSAID-Associated GastropathyNSAID (Non-Steroidal Anti-Inflammatory Drug) Induced Enteropathy
Start date
2021-06-01
Primary completion
2021-12-31
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.